2015: Building a Strong Pipeline
A record 23 chemically distinct, “first-in-field” anti-prostate cancer medicines enter clinical trials within a 12–month window.
A record 23 chemically distinct, “first-in-field” anti-prostate cancer medicines enter clinical trials within a 12–month window.